MoneyWorks4Me

Zydus Lifesciences informs about press release

30 Apr 2025 Evaluate
 Zydus Lifesciences has informed that it enclosed a copy of press release dated April 30, 2025, titled ‘Zydus receives final approval from USFDA for Niacin Extended-Release Tablets USP, 500 mg, 750 mg, and 1,000 mg’. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1231.85
Cipla 1325.00
Lupin 1955.80
Zydus Lifesciences 1124.30
View more..